eligibility for semaglutide Claim Injured Consumers What are the Qualifications for

Highlights: Semaglutide prices in India may drop by up to 70%, improving access to weight-loss and diabetes treatment More than 50 generic versions are expected to enter the market soon after patent expiry Experts caution against misuse , side effects, and the need for strict medical supervision The expiry of Novo Nordisk's semaglutide patent in India on March 20, 2026, marks a turning point in obesity and diabetes care

Is compounded GLP-1 still legal in 2026

Liraglutide, in particular, was associated with an increased incidence of cholelithiasis, whereas other GLP-1RAs, such as exenatide, showed less pronounced associations

Beyond weight reduction, the same trial reported several additional metabolic outcomes as secondary or exploratory endpoints: Improved glycaemic control reductions in HbA1c levels were observed in participants with type 2 diabetes in a separate Phase 2 cohort [3] [4] Reduced waist circumference suggesting a decrease in visceral (abdominal) fat, which is associated with cardiovascular risk Improvements in lipid profiles including reductions in triglycerides Potential signal for benefit in metabolic-associated steatotic liver disease (MASLD) based on the glucagon receptor's proposed role in hepatic fat metabolism

This is not the time to start ambitious new programmes

higher scores indicate a greater severity and a threshold of 10 has high sensitivity and specificity for diagnosis of generalised anxiety disorder [25]